KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Inventory Average (2016 - 2025)

Historic Inventory Average for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.8 billion.

  • Gilead Sciences' Inventory Average fell 731.71% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 731.71%. This contributed to the annual value of $1.7 billion for FY2024, which is 616.27% up from last year.
  • Gilead Sciences' Inventory Average amounted to $1.8 billion in Q3 2025, which was down 731.71% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Inventory Average registered a high of $1.9 billion during Q3 2024, and its lowest value of $1.5 billion during Q3 2022.
  • In the last 5 years, Gilead Sciences' Inventory Average had a median value of $1.7 billion in 2023 and averaged $1.7 billion.
  • As far as peak fluctuations go, Gilead Sciences' Inventory Average surged by 8144.65% in 2021, and later plummeted by 1619.26% in 2022.
  • Over the past 5 years, Gilead Sciences' Inventory Average (Quarter) stood at $1.6 billion in 2021, then decreased by 9.84% to $1.5 billion in 2022, then rose by 16.16% to $1.7 billion in 2023, then grew by 3.74% to $1.8 billion in 2024, then increased by 0.87% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.7 billion during Q1 2025.